Investment, Funding & Disinvestments

The total USD20.9 million funding will be divided into two tranches, with the release of the second contingent on outcomes from the ongoing ‘SEALS’ phase 2 clinical trial.

This new facility aims to help Liberia achieve WHO Maturity Level 3, a benchmark the country has sought for decades without success.

The project, supported by Tariq Almutlaq, Chairman of Daikin Saudi Arabia and a longtime partner, aims to localize production for key HVAC components, including chillers and hydronic heat pumps designed for sophisticated cooling requirements.

The approved funding will help countries build systems that keep communities safe, particularly in cross-border areas where health risks are highest.

The PEN-Plus strategy strengthens local hospitals to diagnose and manage complex illnesses requiring continuous care.

The acquisition centers on Alcyone’s innovative ThecaFlex DRx drug delivery system, an experimental implantable device that represents a significant advancement in treating neurological disorders.

Construction at the MTC is currently underway and is scheduled for completion during the first half of 2027.

This project marks the first hospital of its kind in the Gulf region, blending medical excellence with advanced urban planning.

The pharmaceutical giant will pay USD221.50 per share in cash to purchase the US biotech company, which has developed an innovative platform called drug-Fc conjugates (DFCs).

The acquisition aims to connect ambulatory care centers, teleradiology services, and hospital systems through unified imaging technology.